ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 65 filers reported holding ARCUS BIOSCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,109,229 | -62.9% | 340,347 | -58.0% | 0.00% | -66.7% |
| Q2 2023 | $16,453,720 | -50.9% | 810,129 | -55.9% | 0.00% | -57.1% |
| Q1 2023 | $33,541,682 | +123.3% | 1,838,908 | +153.2% | 0.01% | +133.3% |
| Q4 2022 | $15,018,416 | +1004.3% | 726,229 | +1296.9% | 0.00% | – |
| Q3 2022 | $1,360,000 | -74.4% | 51,990 | -75.2% | 0.00% | -100.0% |
| Q2 2022 | $5,303,000 | +314.9% | 209,283 | +416.6% | 0.00% | – |
| Q1 2022 | $1,278,000 | -85.2% | 40,508 | -81.0% | 0.00% | -100.0% |
| Q4 2021 | $8,641,000 | +483.5% | 213,510 | +402.5% | 0.00% | – |
| Q3 2021 | $1,481,000 | -55.7% | 42,488 | -65.1% | 0.00% | – |
| Q2 2021 | $3,346,000 | -22.5% | 121,849 | -20.7% | 0.00% | -100.0% |
| Q1 2021 | $4,315,000 | -8.8% | 153,652 | -15.7% | 0.00% | -50.0% |
| Q4 2020 | $4,732,000 | +28.9% | 182,313 | -14.9% | 0.00% | +100.0% |
| Q3 2020 | $3,671,000 | -59.9% | 214,184 | -42.1% | 0.00% | -66.7% |
| Q2 2020 | $9,155,000 | +1985.4% | 370,026 | +1071.3% | 0.00% | – |
| Q1 2020 | $439,000 | -23.9% | 31,590 | -44.7% | 0.00% | – |
| Q4 2019 | $577,000 | +15.2% | 57,084 | +3.7% | 0.00% | – |
| Q3 2019 | $501,000 | -9.4% | 55,042 | -20.8% | 0.00% | – |
| Q2 2019 | $553,000 | +152.5% | 69,537 | +296.9% | 0.00% | – |
| Q1 2019 | $219,000 | – | 17,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |